Czech National Bank’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.2M Buy
143,385
+7,917
+6% +$619K 0.09% 205
2025
Q1
$9.82M Buy
135,468
+7,587
+6% +$550K 0.09% 215
2024
Q4
$9.47M Buy
127,881
+5,166
+4% +$382K 0.09% 205
2024
Q3
$8.1M Buy
122,715
+7,883
+7% +$520K 0.08% 230
2024
Q2
$10.6M Buy
114,832
+8,118
+8% +$750K 0.12% 159
2024
Q1
$10.2M Buy
106,714
+489
+0.5% +$46.7K 0.13% 157
2023
Q4
$8.1M Sell
106,225
-27
-0% -$2.06K 0.12% 177
2023
Q3
$7.36M Buy
106,252
+34,487
+48% +$2.39M 0.12% 171
2023
Q2
$6.77M Sell
71,765
-1,070
-1% -$101K 0.15% 134
2023
Q1
$6.03M Buy
72,835
+462
+0.6% +$38.2K 0.15% 137
2022
Q4
$5.4M Buy
72,373
+327
+0.5% +$24.4K 0.14% 155
2022
Q3
$5.95M Buy
+72,046
New +$5.95M 0.17% 127